netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 30 of 36

Older Oldest

Details
LDL Link Added : MHRA Drug Safety Update (Aug 2019): Carfilzomib (Kyprolis▼): reminder of risk of potentially fatal cardiac events : https://www.gov.uk/drug-safety-update/carfilzomib-kyprolis-reminder-of-risk-of-potentially-fatal-cardiac-events
11/07/2023 17:56:18
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (Dec 2019): Carfilzomib (Kyprolis▼): risk of reactivation of hepatitis B virus : https://www.gov.uk/drug-safety-update/carfilzomib-kyprolis-risk-of-reactivation-of-hepatitis-b-virus
11/07/2023 17:55:54
(dmcdermott )
UPD sitematrix Changed from 0 to
11/07/2023 17:55:21
(dmcdermott )
UPD FurtherInformation Changed from
11/07/2023 17:55:21
(dmcdermott )
UPD Carfilzomib (Kyprolis®) =
11/07/2023 17:55:21
(dmcdermott )
UPD sitematrix Changed from 0 to
27/07/2022 14:48:34
(DavidS )
UPD BlueTeq Changed from N to Y
27/07/2022 14:48:34
(DavidS )
UPD Carfilzomib (Kyprolis®) updated
27/07/2022 14:48:34
(DavidS )
UPD sitematrix Changed from 0 to
27/07/2022 14:44:58
(LoweryM )
UPD FurtherInformation Changed from
27/07/2022 14:44:58
(LoweryM )
UPD Carfilzomib (Kyprolis®) strength removed
27/07/2022 14:44:58
(LoweryM )
UPD sitematrix Changed from 0 to
27/07/2022 14:44:25
(DavidS )
UPD BlueTeq Changed from N to Y
27/07/2022 14:44:25
(DavidS )
UPD FurtherInformation Changed from
27/07/2022 14:44:25
(DavidS )
UPD Carfilzomib (Kyprolis®) updated formatting
27/07/2022 14:44:25
(DavidS )
UPD sitematrix Changed from 0 to
27/07/2022 14:44:24
(DavidS )
UPD BlueTeq Changed from N to Y
27/07/2022 14:44:24
(DavidS )
UPD FurtherInformation Changed from
27/07/2022 14:44:24
(DavidS )
UPD Carfilzomib (Kyprolis®) updated formatting
27/07/2022 14:44:24
(DavidS )
UPD sitematrix Changed from 0 to
26/04/2022 11:12:15
(DavidS )
UPD isHC Changed from N to Y
26/04/2022 11:12:15
(DavidS )
UPD isCyto Changed from 0 to 1
26/04/2022 11:12:15
(DavidS )
UPD Carfilzomib (Kyprolis®) updated
26/04/2022 11:12:15
(DavidS )
LDL Link Added : NICE TA695: Carfilzomib with dexamethasone and lenalidomide for previously treated multiple myeloma : https://www.nice.org.uk/guidance/ta695/chapter/1-Recommendations
21/09/2021 10:37:57
(DavidS )
UPD sitematrix Changed from 0 to
21/09/2021 10:37:33
(DavidS )
UPD FurtherInformation Changed from
  • 10mg, 30mg & 60mg powder for solution for infusion
  • Approved for use in previously treated multiple myeloma in line with NICE and NHSE Commissioning Policy

 

to <
21/09/2021 10:37:33
(DavidS )
UPD Carfilzomib (Kyprolis®) NICE TA695
21/09/2021 10:37:33
(DavidS )
UPD Carfilzomib (Kyprolis®) updated
20/05/2021 13:43:18
(LoweryM )
UPD Carfilzomib (Kyprolis®) formatting updated
19/05/2021 16:44:15
(DavidS )
LDL Link Added : NICE TA657: Carfilzomib for previously treated multiple myeloma (COVID-19) : https://www.nice.org.uk/guidance/ta657
26/02/2021 10:54:37
(DavidS )

 

 
netFormulary